ArticleAnalytical and bioanalytical chemistry2020
Double molecular recognition strategy based on boronic acid-diol and NHS ester-amine for selective electrochemical detection of cerebral dopamine.
Article in Analytical and bioanalytical chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 6 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
Electrochemical detection of dopamine (DA) usually depends on electrochemical oxidation of DA. This conventional method can hardly provide sufficient sensitivity and selectivity in the determination of the cerebral DA down to nanomolar level, because the ability of DA to be electrochemically oxidized is limited and many electroactive interferents are also oxidized at a similar potential with DA. Here, an electrochemical assay based on a double molecular recognition strategy has been proposed and proved to be of high sensitivity and selectivity for DA measurement in the cerebral system. 3,3'-Dithiodipropionic acid di(N-hydroxysuccinimide ester) (DSP) was anchored on the electrode surface to capture DA target through the specific reaction between N-hydroxysuccinimide (NHS) ester and amine. The captured DA endowed the electrode with a layer of diol groups, which further reacted with the boronic acid to trap of 4-mercaptophenylboronic acid (MBA) molecules, thus leading to the conjunction of electroactive thionine (Th) molecules on the electrode for signal readout. In addition, an Au nanostructure was employed to enhance signal amplification and facilitate the double molecular recognition process. As a consequence, this method was able to quantify DA from 1 to 300 nM with a detection limit of 0.74 nM, which exhibited a high specificity against cerebral interferents. Furthermore, the practicability of this platform was successfully demonstrated through determination of the dynamics of cerebral DA in the events of high K
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.